Live Breaking News & Updates on Translational Breast Cancer Research Consortium

Stay updated with breaking news from Translational breast cancer research consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology

LOS ANGELES (BUSINESS WIRE) Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that the results of the Phase II TBCRC041 randomized clinical trial of alisertib alone or in combination with fulvestrant in patients with endocrine-resistant advanced breast cancer have been published onlin. ....

United States , Tufiac Haddad , Alanh Auerbach , Mayo Clinic College Of Medicine , European Commission , Drug Administration , Puma Biotechnology Inc , Translational Breast Cancer Research Consortium , Mayo Clinic Comprehensive Cancer Center , Puma Biotechnology , Translational Breast Cancer Research , Associate Professor , Mayo Clinic College , Digital Innovation , Mayo Clinic Comprehensive Cancer , Chief Executive Officer ,

Anixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board

/PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,. ....

United States , Arnold Baskies , Mike Catelani , Brian Leyland Jones , Anixa Biosciences , Vincent Tuohy , Amit Kumar , Pamelad Garzone , G Thomas Budd , Molgenie Gmb , Lisah Butterfield , Brian Czerniecki , Biosystems Inc , Global Cancer Control Advisory Council , Cleveland Clinic Cancer Center , Oncology Program , Department Of Medicine , Accelerator Fund , Case Comprehensive Cancer Center , Drug Administration , World Health Organization , American Association For Cancer Research , Anixa Biosciences Inc , Virtua Health Systems , Translational Breast Cancer Research Consortium , Innovative Breast Cancer Research ,

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial | Critical Care Medicine | JAMA

This secondary analysis of an ongoing adaptive platform trial examines the effect of multiple interventions for critically ill adults with COVID-19 on longer-te ....

United Kingdom , South Australia , France General , City Of , British Columbia , United States , Western Australia , San Francisco , New Zealand General , New Zealand , Estado De Pernambuco , National University , Eteläuomen Läi , Sao Paulo , Sri Lanka , Ar Riya , Saudi Arabia , Îe De France , Krung Thep Mahanakhon , Montigny Le Bretonneux , Charlottea Bradbury , Srinivas Murthy , Alistaird Nichol , Herman Goossens , Kathrynm Rowan , Marcjm Bonten ,

Clinical Trial: Niraparib Plus Trastuzumab in Metastatic HER2+ Breast Cancer

Researchers are conducting a phase 1b/2 study to test the safety and efficacy of niraparib plus trastuzumab in metastatic HER2+ breast cancer. ....

University Of Alabama At Birmingham , United States , Susang Komen Breast Cancer Foundation , Tesaro Inc , Translational Breast Cancer Research Consortium , Breast Cancer Research Foundation Of Alabama , Erica Stringer Reasor , Breast Cancer Foundation , Breast Cancer Research Foundation ,

Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium

Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Antonio , David Schull , Rachela Freedman , Alanh Auerbach , European Commission , Drug Administration , Susanf Smith Center , Exchange Commission , Puma Biotechnology Inc , Translational Breast Cancer Research Consortium , Dana Farber Cancer Institute , Breast Oncology Center , Wall Street , Antonio Breast Cancer Symposium , Breast Cancer Brain Metastases , Spotlight Poster Session , Response Assessment , Neuro Oncology Brain Metastases , Response Rate , Dana Farber Cancer , Puma Biotechnology , Puma Patient Lynx , Fetal Toxicity , Full Prescribing Information , Annual Report ,